| Lead Manager/ | # of | Price Range | Dollar | SCOOP | ||
| New Filings (Proposed Symbol) | Joint-Lead Managers | Shares | Low | High | Volume | Ratings |
| EndoStim (STIM) | Wedbush PacGrow Life Sciences | $40.25 | n.a. | |||
| Upland Software (UPLD) | William Blair/ Raymond James | $50.00 | n.a. | |||
| Neff Corporation (NEFF) | Morgan Stanley/ Jefferies/ Piper Jaffray | $100.00 | n.a. | |||
| n.a. (not available) | ||||||
| Postponed | ||||||
| None | ||||||
| Withdrawn | ||||||
| None | ||||||
| New Terms | ||||||
| Affimed Therapeutics B.V. (AFMD) | Jefferies/ Leerink Partners/ BMO Capital Markets | 6.25 | $11.00 | $13.00 | $75.00 | 2-Stars |
| Alibaba Group Holding (BABA) | Credit Suisse/ Deutsche Bank Securities/ Goldman Sachs/ J.P. Morgan/ Morgan Stanley/ Citi | 320.10 | $60.00 | $66.00 | $20,166.37 | n.a. |
| Civitas Solutions (CIVI) | Barclays/ Jefferies/ BofA Merrill Lynch/ UBS Investment Bank | 11.70 | $20.00 | $23.00 | $251.55 | n.a. |
| Foamix Ltd. (FOMX) | Barclays/ Cowen and Company | 5.91 | $10.00 | $12.00 | $65.00 | n.a. |
| GWG Holdings (GWGH) | Newport Coast Securities/ Axiom Capital Management/ Newbridge Securities | 1.25 | $11.50 | $13.50 | $15.63 | n.a. |
| Product Shipping Limited (PROS) | Morgan Stanley | $100.00 | n.a. | |||
| rEVO Biologics (RBIO) | Piper Jaffray/ Guggenheim Securities | 3.60 | $13.00 | $15.00 | $50.40 | 1-Star |
| Tokai Pharmaceuticals (TKAI) | BMO Capital Markets/ Stifel/ William Blair | 5.40 | $13.00 | $15.00 | $75.60 | n.a. |
| Viking Therapeutics (VKTX) | Oppenheimer/ Roth Capital Partners | 5.00 | $10.00 | $12.00 | $55.00 | n.a. |
| IPOs Priced | Lead | Shares | Amount | Offer | Close | % |
| Week of Sept. 1, 2014 | Manager(s) | Offered | Raised | Price | 9/5/14 | Change |
| None | ||||||
